A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers
Starting soon · Phase 1 · Has a placebo group
Conditions studied: Healthy Participants
In brief
The main purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) of AZD4916 in healthy adult participants.
Key facts
- Study ID
- NCT06951880
- Run by
- AstraZeneca
- People needed
- 160
- Starts
- 2026-07-23
- Expected to finish
- 2027-10-25
- Last updated by the study team
- 2026-06-15
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Research Site — Glendale, California, United States
- Research Site — Harrow, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.